Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12964-024-01714-7.

Title:
The role of KLRG1: a novel biomarker and new therapeutic target | Cell Communication and Signaling
Description:
Killer cell lectin-like receptor G1 (KLRG1) is an immune checkpoint receptor expressed predominantly in NK and T-cell subsets that downregulates the activation and proliferation of immune cells and participates in cell-mediated immune responses. Accumulating evidence has demonstrated the importance of KLRG1 as a noteworthy disease marker and therapeutic target that can influence disease onset, progression, and prognosis. Blocking KLRG1 has been shown to effectively mitigate the effects of downregulation in various mouse tumor models, including solid tumors and hematologic malignancies. However, KLRG1 inhibitors have not yet been approved for human use, and the understanding of KLRG1 expression and its mechanism of action in various diseases remains incomplete. In this review, we explore alterations in the distribution, structure, and signaling pathways of KLRG1 in immune cells and summarize its expression patterns and roles in the development and progression of autoimmune diseases, infectious diseases, and cancers. Additionally, we discuss the potential applications of KLRG1 as a tool for tumor immunotherapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Health & Fitness
  • Education

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't see how the site brings in money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {πŸ”}

klrg, pubmed, cells, article, google, scholar, cell, cas, expression, immune, cancer, tcells, central, tumor, immunol, patients, receptor, infection, killer, effector, function, role, inhibitory, tcell, disease, activation, mouse, diseases, human, antitumor, signaling, proliferation, tumors, autoimmune, pathway, inhibit, memory, immunity, lectinlike, expressed, protein, activity, mice, increased, therapeutic, regulatory, immunotherapy, ampk, antibody, target,

Topics {βœ’οΈ}

tumor-infiltrating effector t-cells short-lived effector cd8 human cd4 + t-cell immunity klrg1+cd127βˆ’cd8+ t-cells klrg1βˆ’cd127+cd8+ t-cells pd-1/pd-l1 signaling pathway nkt cell-targeted vaccination hcv-infected cd4+ t-cells article download pdf distinct disulfide-mediated oligomerizations amp-responsive protein kinase beta-catenin nuclear signalling cell receptor-induced bmi-1 tumor necrosis factor-alpha cell-mediated immune responses increased klrg1+cd4+ t-cells exhausted hcv-specific cd8 + t-cell exhaustion characterized reprogram tumor-exposed nk tumor-infiltrating t-cells c-type lectin family e-cadherin reveals basis anti-pd-1 antibody controls tumor necroptosis-mediated shedding t-bet transcription factor anti-4-1bb mab revealed driven cd4+ t-cells antigen-specific human cd8 + cd8+ t-cells lose klrg1-related studies based hinder t-cell function inhibitory c-type lectin membrane-bound n-cad suppressing anti-tumor immunity anti-klrg1 antibody inhibited b-cell lymphoma-2 rbl-2h3 mast cells lung cd4+ t-cells anti-klrg1 monoclonal antibodies e-cad/klrg1 pathway plays cd8+ t-cell differentiation em-myc lymphoma model van ginderachter ja klrg1βˆ’cd4+ t-cells [90] increasing t-cell infiltration klrg1+ t-cell infiltration future anti-klrg1 drugs soluble n-cad released e-cadherin/catenin complex klrg1+cd8+ t-cells

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:The role of KLRG1: a novel biomarker and new therapeutic target
         description:Killer cell lectin-like receptor G1 (KLRG1) is an immune checkpoint receptor expressed predominantly in NK and T-cell subsets that downregulates the activation and proliferation of immune cells and participates in cell-mediated immune responses. Accumulating evidence has demonstrated the importance of KLRG1 as a noteworthy disease marker and therapeutic target that can influence disease onset, progression, and prognosis. Blocking KLRG1 has been shown to effectively mitigate the effects of downregulation in various mouse tumor models, including solid tumors and hematologic malignancies. However, KLRG1 inhibitors have not yet been approved for human use, and the understanding of KLRG1 expression and its mechanism of action in various diseases remains incomplete. In this review, we explore alterations in the distribution, structure, and signaling pathways of KLRG1 in immune cells and summarize its expression patterns and roles in the development and progression of autoimmune diseases, infectious diseases, and cancers. Additionally, we discuss the potential applications of KLRG1 as a tool for tumor immunotherapy.
         datePublished:2024-06-19T00:00:00Z
         dateModified:2024-06-19T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12964-024-01714-7
         keywords:
            KLRG1
            Immune checkpoint proteins
            Biomarker
            Therapeutic target
            Tumor immunotherapy
            Cell Biology
            Protein-Ligand Interactions
            Receptors
            Cytokines and Growth Factors
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-024-01714-7/MediaObjects/12964_2024_1714_Fig1_HTML.png
         isPartOf:
            name:Cell Communication and Signaling
            issn:
               1478-811X
            volumeNumber:22
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yakun Zhang
               affiliation:
                     name:Chongqing University
                     address:
                        name:School of Medicine, Chongqing University, Chongqing, China
                        type:PostalAddress
                     type:Organization
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shuang Chen
               affiliation:
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xinyi Tang
               affiliation:
                     name:Chongqing University
                     address:
                        name:School of Medicine, Chongqing University, Chongqing, China
                        type:PostalAddress
                     type:Organization
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu Peng
               affiliation:
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tingting Jiang
               affiliation:
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaomei Zhang
               affiliation:
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jun Li
               affiliation:
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yao Liu
               affiliation:
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Zailin Yang
               affiliation:
                     name:Chongqing University Cancer Hospital
                     address:
                        name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The role of KLRG1: a novel biomarker and new therapeutic target
      description:Killer cell lectin-like receptor G1 (KLRG1) is an immune checkpoint receptor expressed predominantly in NK and T-cell subsets that downregulates the activation and proliferation of immune cells and participates in cell-mediated immune responses. Accumulating evidence has demonstrated the importance of KLRG1 as a noteworthy disease marker and therapeutic target that can influence disease onset, progression, and prognosis. Blocking KLRG1 has been shown to effectively mitigate the effects of downregulation in various mouse tumor models, including solid tumors and hematologic malignancies. However, KLRG1 inhibitors have not yet been approved for human use, and the understanding of KLRG1 expression and its mechanism of action in various diseases remains incomplete. In this review, we explore alterations in the distribution, structure, and signaling pathways of KLRG1 in immune cells and summarize its expression patterns and roles in the development and progression of autoimmune diseases, infectious diseases, and cancers. Additionally, we discuss the potential applications of KLRG1 as a tool for tumor immunotherapy.
      datePublished:2024-06-19T00:00:00Z
      dateModified:2024-06-19T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12964-024-01714-7
      keywords:
         KLRG1
         Immune checkpoint proteins
         Biomarker
         Therapeutic target
         Tumor immunotherapy
         Cell Biology
         Protein-Ligand Interactions
         Receptors
         Cytokines and Growth Factors
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12964-024-01714-7/MediaObjects/12964_2024_1714_Fig1_HTML.png
      isPartOf:
         name:Cell Communication and Signaling
         issn:
            1478-811X
         volumeNumber:22
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yakun Zhang
            affiliation:
                  name:Chongqing University
                  address:
                     name:School of Medicine, Chongqing University, Chongqing, China
                     type:PostalAddress
                  type:Organization
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shuang Chen
            affiliation:
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xinyi Tang
            affiliation:
                  name:Chongqing University
                  address:
                     name:School of Medicine, Chongqing University, Chongqing, China
                     type:PostalAddress
                  type:Organization
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu Peng
            affiliation:
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tingting Jiang
            affiliation:
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaomei Zhang
            affiliation:
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jun Li
            affiliation:
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yao Liu
            affiliation:
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Zailin Yang
            affiliation:
                  name:Chongqing University Cancer Hospital
                  address:
                     name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Communication and Signaling
      issn:
         1478-811X
      volumeNumber:22
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Chongqing University
      address:
         name:School of Medicine, Chongqing University, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University
      address:
         name:School of Medicine, Chongqing University, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
      name:Chongqing University Cancer Hospital
      address:
         name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yakun Zhang
      affiliation:
            name:Chongqing University
            address:
               name:School of Medicine, Chongqing University, Chongqing, China
               type:PostalAddress
            type:Organization
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Shuang Chen
      affiliation:
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Xinyi Tang
      affiliation:
            name:Chongqing University
            address:
               name:School of Medicine, Chongqing University, Chongqing, China
               type:PostalAddress
            type:Organization
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Yu Peng
      affiliation:
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Tingting Jiang
      affiliation:
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Xiaomei Zhang
      affiliation:
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Jun Li
      affiliation:
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Yao Liu
      affiliation:
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Zailin Yang
      affiliation:
            name:Chongqing University Cancer Hospital
            address:
               name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:School of Medicine, Chongqing University, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:School of Medicine, Chongqing University, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China
      name:Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China

External Links {πŸ”—}(457)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

5.47s.